Author

Vanessa S. Silveira

Broad InstituteORCID 0000-0001-5633-9490Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Vanessa S. Silveira1 paper · Harvard University

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:proteomics· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alexandra PopaiD· 1 shared Austin E. EadesiD· 1 shared Bailey A. ByeiD· 1 shared Costas Andreas LyssiotisiD· 1 shared Cristina Rosa FerroneiD· 1 shared Cyril H. BenesiD· 1 shared David E. RootiD· 1 shared Dejan JuriciD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexandra PopaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyScientific ReportsPeer-reviewedSep 30, 2025

DUSP6 is upregulated in metastasis and influences migration and metabolism in pancreatic cancer cells

Mariana T. Ruckert, R. McKinnon Walsh, Bailey A. Bye…·Vanessa S. Silveira

This study shows DUSP6 is upregulated in pancreatic cancer metastasis and independently influences cell migration and metabolism, suggesting it as a therapeutic target.

4 citations

humanbulk RNA-seq

Cancer BiologyCancer DiscoveryPeer-reviewedMay 12, 2025

Generation of a biliary tract cancer cell line atlas reveals molecular subtypes and therapeutic targets

Vindhya Vijay, Negin Karisani, Lei Shi…·Nabeel M. Bardeesy

This study creates a biliary tract cancer cell line atlas using multi-omics data to identify molecular subtypes and therapeutic targets.

20 citationstop 1%

humanbulk RNA-seq